Suchergebnisse - "Louzada, Martha L"

PubPharm (24)

1

Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma : a phase 1/2 trial

enthalten in: Nature medicine | 2024

von Trudel, S. | McCurdy, A. | Louzada, M. | +10

2

First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma : Recommendations from the Canadian Myeloma Research Group Consensus Guideline Consortium

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Côté, J. | Kotb, R. | Bergstrom, D. | +4

3

Management of Myeloma Manifestations and Complications : The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium

enthalten in: Clinical lymphoma, myeloma & leukemia | 2022

von LeBlanc, R. | Bergstrom, D. | Côté, J. | +3

4

Retrospective study of treatment patterns and outcomes post-lenalidomide for multiple myeloma in Canada

enthalten in: European journal of haematology | 2021

von Reece, D. | Masih-Khan, E. | Atenafu, E. | +14

5

Thrombosis and myeloma : it is time to get the elephant out of the room

enthalten in: British journal of haematology | 2021

von Louzada, M.

CommentOn: Br J Haematol. 2021 Jun;193(6):1213-1219. - PMID 33997961

6

Retrospective study of treatment patterns and outcomes post‐lenalidomide for multiple myeloma in Canada

enthalten in: European Journal of Haematology | 2021

von Reece, D. | Masih‐Khan, E. | Atenafu, E. | +14

7

Thrombophilia testing in patients receiving rivaroxaban or apixaban for the treatment of venous thromboembolism

enthalten in: Thrombosis research | 2020

von Kovacs, M. | Lazo-Langner, A. | Louzada, M. | +1

8

Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders : Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium

enthalten in: Clinical lymphoma, myeloma & leukemia | 2020

von Bergstrom, D. | Kotb, R. | Louzada, M. | +22

9

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study

enthalten in: BMC hematology | 2016

von Louzada, M. | Hsia, C. | Al-Ani, F. | +7

10

Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study

enthalten in: BMC hematology | 2016

von Louzada, M. | Hsia, C. | Al-Ani, F. | +7